PR Towards better quality of life, GNT Pharma

언론보도

지엔티파마 GedaCure 승인 글로벌 보도자료

페이지 정보

profile_image

작성자 GNTPharma

조회 5,160회 작성일 2021-02-25 16:53

본문

GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome

https://www.businesswire.com/news/home/20210210005036/en

GedaCure® von GNT Pharma für die Behandlung von Hunden mit kognitiven Funktionsstörungen zugelassen

https://www.businesswire.com/news/home/20210210005254/de/

Le GedaCure® de GNT Pharma est approuvé pour le traitement des chiens atteints du syndrome de dysfonctionnement cognitif

https://www.businesswire.com/news/home/20210210005041/fr/

Se aprueba GedaCure® de GNT Pharma para el tratamiento de perros con síndrome de disfunción cognitiva

https://www.businesswire.com/news/home/20210210005037/es/

GedaCure® da GNT Pharma aprovado para o tratamento de cães com síndrome de disfunção cognitiva

https://www.businesswire.com/news/home/20210210005039/pt/

GedaCure® di GNT Pharma approvato per il trattamento di cani con sindrome da disfunzione cognitiva

https://www.businesswire.com/news/home/20210210005038/it/

GedaCure® van GNT Pharma goedgekeurd voor de behandeling van honden met cognitief disfunctiesyndroom

https://www.businesswire.com/news/home/20210210005044/nl/

GNTファーマのGedaCure®が犬の認知障害症候群の治療薬として承認される

https://www.businesswire.com/news/home/20210210005040/ja/

GNT Pharma的GedaCure®获准用于治疗犬类认知功能障碍综合征

https://www.businesswire.com/news/home/20210210005042/zh-CN/

GNT Pharma的GedaCure®獲准用於治療犬類認知功能障礙症候群

https://www.businesswire.com/news/home/20210210005043/zh-HK/

عقار جيداكيور ®GedaCure من جي إن تي فارما يحظى بالموافقة لعلاج الكلاب المصابة بمتلازمة الخلل الوظيفي الإدراكي
https://bit.ly/3rLs37N